Recent Developments
missing en-it translation: common.latest-movements-copy
- Market capitalization
- US$8.03M
- 24h volume in the Italian market
- US$489,074
- Circulating supply
- 8,32B ISP
Earn up to
60% APY on your investments.
A comprehensive guide on how to lend Ispolink (ISP) in the Italian market
We have a wealth of information on lending Ispolink (ISP), and we are pleased to share some of this with you.
We present you with various lending options featuring alternative cryptocurrencies that may pique your interest.
missing en-it translation: common.latest-movements-copy

Lending Ispolink can be an excellent choice for those looking to hold ISP while generating a return. The process may seem a bit intimidating, particularly for first-timers. That’s why we’ve created this guide to help you navigate through it.
To lend Ispolink, you must first possess it. To acquire Ispolink, you'll need to buy it. You can select from these well-known exchanges available in Italy.
| Piattaforma | Criptovaluta | Value |
|---|---|---|
| Azbit | Ispolink (ISP) | 0,0001 APY |
| Bitmart | Ispolink (ISP) | 0,000315 APY |
| Gate.io | Ispolink (ISP) | 0,00009034 APY |
| Kucoin | Ispolink (ISP) | 0,0000903 APY |
| MEXC Global | Ispolink (ISP) | 0,00009009 APY |
| Probit | Ispolink (ISP) | 0,0001043 APY |
Once you have ISP, you'll need to select a Ispolink lending platform to lend your tokens. You can explore some options here.
| Piattaforma | Criptovaluta | APY |
|---|---|---|
| Kucoin | Ispolink (ISP) | Up to 60% APY |
Once you've selected a platform to lend your Ispolink, transfer your Ispolink into your wallet on the lending platform. After the deposit is made, it will begin to accrue interest. Some platforms offer interest payments daily, while others do so weekly or monthly.
Now all you need to do is relax while your cryptocurrency earns APY. The more you deposit, the higher your potential returns. Ensure that your lending platform offers compounding interest to maximize your earnings.
Lending your cryptocurrency can involve significant risks